These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1560441)

  • 1. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
    Gordon RK; Breuer E; Padilla FN; Smejkal RM; Chiang PK
    Mol Pharmacol; 1989 Nov; 36(5):766-72. PubMed ID: 2586491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desethylaprophen: a metabolite of aprophen with antimuscarinic activities.
    Brown ND; Smejkal RM; Breuer E; Doctor BP; Chiang PK
    J Pharm Sci; 1988 Feb; 77(2):145-8. PubMed ID: 3258910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Christophe J
    Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
    Carroll FI; Abraham P; Parham K; Griffith RC; Ahmad A; Richard MM; Padilla FN; Witkin JM; Chiang PK
    J Med Chem; 1987 May; 30(5):805-9. PubMed ID: 3494849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.
    Baumgold J; Cohen VI; Paek R; Reba RC
    Life Sci; 1991; 48(24):2325-9. PubMed ID: 2046461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM; Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M1, M2 and M4.
    Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Tacke R; Christophe J
    Eur J Pharmacol; 1990 Sep; 189(2-3):135-42. PubMed ID: 2253700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies.
    Louie DS; Owyang C
    Am J Physiol; 1986 Aug; 251(2 Pt 1):G275-9. PubMed ID: 2426974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of porcine coronary muscarinic receptors.
    Entzeroth M; Doods HN; Mayer N
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):432-8. PubMed ID: 2366878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells.
    Mauduit P; Jammes H; Rossignol B
    Am J Physiol; 1993 Jun; 264(6 Pt 1):C1550-60. PubMed ID: 8333505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.
    Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
    Chirality; 1991; 3(2):118-23. PubMed ID: 1863523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
    Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S
    Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
    Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
    J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G
    Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.